Company Filing History:
Years Active: 2012-2015
Title: Osama N El-Assal: Innovator in Medical Treatments
Introduction
Osama N El-Assal is a notable inventor based in Gahanna, OH (US). He has made significant contributions to the field of medicine, particularly in the treatment of intestinal injuries related to hemorrhagic shock. With a total of 2 patents, his work is paving the way for improved clinical outcomes in patients facing critical health challenges.
Latest Patents
El-Assal's latest patents focus on the use of heparin binding epidermal growth factor (HB-EGF) for treating and preventing intestinal injury associated with hemorrhagic shock and resuscitation. The invention outlines methods to protect, prevent, and reduce intestinal injury in human subjects who are suffering from or at risk for shock. By administering HB-EGF, the methods aim to inhibit the deterioration of intestinal blood flow and enhance its preservation and increase. These innovative approaches are designed to improve the clinical outcomes for individuals experiencing shock, hemorrhagic shock, or related conditions.
Career Highlights
Osama N El-Assal is affiliated with Nationwide Children's Hospital, Inc., where he continues to advance his research and innovations. His work is instrumental in developing new therapeutic strategies that address critical medical issues.
Collaborations
El-Assal collaborates with esteemed professionals in his field, including Gail E Besner, to further enhance the impact of his inventions and research.
Conclusion
Osama N El-Assal's contributions to medical science through his patents and research are vital for improving treatment methods for patients at risk of intestinal injuries due to hemorrhagic shock. His innovative approaches are set to make a significant difference in clinical practices.